Smith & Nephew PLC (SNN)
25.59
+0.31
(+1.23%)
USD |
NYSE |
Nov 05, 16:00
25.59
0.00 (0.00%)
After-Hours: 19:45
Smith & Nephew Enterprise Value: 13.92B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 13.92B |
| November 01, 2024 | 13.91B |
| October 31, 2024 | 13.84B |
| October 30, 2024 | 15.48B |
| October 29, 2024 | 15.49B |
| October 28, 2024 | 15.48B |
| October 25, 2024 | 15.27B |
| October 24, 2024 | 15.76B |
| October 23, 2024 | 15.65B |
| October 22, 2024 | 15.74B |
| October 21, 2024 | 15.71B |
| October 18, 2024 | 15.79B |
| October 17, 2024 | 15.70B |
| October 16, 2024 | 15.49B |
| October 15, 2024 | 15.32B |
| October 14, 2024 | 15.38B |
| October 11, 2024 | 15.29B |
| October 10, 2024 | 15.35B |
| October 09, 2024 | 15.49B |
| October 08, 2024 | 15.32B |
| October 07, 2024 | 15.46B |
| October 04, 2024 | 15.98B |
| October 03, 2024 | 16.03B |
| October 02, 2024 | 16.13B |
| October 01, 2024 | 16.35B |
| Date | Value |
|---|---|
| September 30, 2024 | 16.48B |
| September 27, 2024 | 16.47B |
| September 26, 2024 | 16.33B |
| September 25, 2024 | 16.20B |
| September 24, 2024 | 16.22B |
| September 23, 2024 | 16.27B |
| September 20, 2024 | 16.23B |
| September 19, 2024 | 16.40B |
| September 18, 2024 | 16.29B |
| September 17, 2024 | 16.40B |
| September 16, 2024 | 16.64B |
| September 13, 2024 | 16.64B |
| September 12, 2024 | 16.57B |
| September 11, 2024 | 16.65B |
| September 10, 2024 | 16.70B |
| September 09, 2024 | 16.67B |
| September 06, 2024 | 16.63B |
| September 05, 2024 | 16.52B |
| September 04, 2024 | 16.31B |
| September 03, 2024 | 16.27B |
| August 30, 2024 | 16.35B |
| August 29, 2024 | 16.40B |
| August 28, 2024 | 16.43B |
| August 27, 2024 | 16.49B |
| August 26, 2024 | 16.31B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.74B
Minimum
Sep 27 2022
24.20B
Maximum
Feb 20 2020
16.80B
Average
16.20B
Median
Jul 21 2023
Enterprise Value Benchmarks
| Haleon PLC | 54.64B |
| Adaptimmune Therapeutics PLC | 18.55M |
| Biodexa Pharmaceuticals PLC | -2.612M |
| Verona Pharma PLC | 2.817B |
| NuCana PLC | -11.24M |
Enterprise Value Related Metrics
| Earnings Yield | 2.73% |
| Operating Earnings Yield | 6.38% |
| Normalized Earnings Yield | 2.728 |